株探米国株
日本語 英語
エドガーで原本を確認する
false 0001892322 0001892322 2024-11-14 2024-11-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): November 14, 2024

 

HEARTCORE ENTERPRISES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41272   87-0913420

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

1-2-33, Higashigotanda, Shinagawa-ku, Tokyo, Japan

(Address of principal executive offices)

 

+81-3-6409-6966

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   HTCR   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On November 14, 2024, HeartCore Enterprises, Inc. (the “Company”) issued a press release announcing financial results for the quarter ended September 30, 2024. A copy of this press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information contained in any website is not a part of this Current Report on Form 8-K.

 

The information included in this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit

No.

  Description
99.1   Press release of the registrant dated November 14, 2024.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  HEARTCORE ENTERPRISES, INC.
   
Dated: November 14, 2024 By: /s/ Sumitaka Yamamoto
  Name: Sumitaka Yamamoto
  Title: Chief Executive Officer

 

 

 

EX-99.1 2 ex99-1.htm

 

Exhibit 99.1

 

 

HeartCore Reports Third Quarter 2024 Financial Results

 

Q3 2024 Revenues Increased 281% to $17.9 Million

Q3 2024 Net Income Increased 526% to $10.8 Million

 

NEW YORK and TOKYO, November 14, 2024 (GLOBE NEWSWIRE) – HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and consulting services company based in Tokyo, reported financial results for the third quarter ended September 30, 2024.

 

Third Quarter 2024 and Recent Operational Highlights

 

Regained compliance with Nasdaq Listing Requirements
Expanded CMS platform offering into a SaaS delivery model
Entered into a sales collaboration with Tosho Computer Systems Co., Ltd.
Announced transition from annual contracts to multi-year agreements for core software business contracts
Partnered with NTT Data Business Brains Corporation to enhance website development service capabilities
Achieved top market share in Japan for nine consecutive years
Awarded new contract from Fourmix Co., Ltd. to implement CMS platform
Announced Go IPO Client, SBC Medical Group Holdings Incorporated, began trading on the Nasdaq Stock Exchange
Partnered with INCUDATA Corp. to enhance corporate digital marketing strategies
Announced Go IPO Client, BloomZ Inc., began trading on the Nasdaq Stock Exchange
Authorized second dividend payment of $0.02 per share
Partnered with Hitachi Systems, Ltd. to offer combined package of HeartCore CMS and GRED Web Security Assessment Cloud

 

Management Commentary

 

“I am pleased to announce the strongest quarter of HeartCore’s history, supported by the progress made across our Go IPO business,” said HeartCore CEO Sumitaka Kanno. “The third quarter saw two new Go IPO clients successfully listed on the Nasdaq. The warrants and ordinary shares received from these deals contributed to our highest financial results since the inception of the service, driving us into profitable operations for the quarter and year-to-date. This quarter’s results showcased the immense value of our consulting business, and with an optimistic outlook on the U.S. IPO market for Japanese companies, we anticipate closing additional deals over the next several months that will further support the growth of our Go IPO business. We continue to remain in serious discussions with prospective Go IPO clients and look forward to sharing future wins as they come.”

 

“We also accomplished key developments in our software business, positioning us for sustained and predictable growth in the coming quarters. First, we transitioned towards offering multi-year software licensing agreements to our customers, a move designed to generate recurring revenue streams and enhance our margin profile. Furthermore, we added a SaaS delivery model for our CMS platform designed to support our sales and marketing team to tap into a new pool of prospective customers. While Go IPO contains the prospect of significant upside, our adjustments in the software business model are intended to create more stable, durable, and long-term revenue for future quarters. We look forward to continuing driving growth across both arms of the business and carrying this momentum into 2025.”

 

 

 

 

Third Quarter 2024 Financial Results

 

Revenues increased 281% to $17.9 million compared to $4.7 million in the same period last year. The increase was primarily due to revenue from warrants and ordinary shares associated with the successful listing of two Go IPO consulting service clients.

 

Gross profit increased 1,640% to $14.4 million compared to $0.8 million in the same period last year. The increase was primarily due to the aforementioned reason above.

 

Operating expenses decreased to $2.3 million compared to $2.6 million in the same period last year. The improvement was primarily due to lower selling, general and administrative, and research and development expenses.

 

Net income increased 526% to $10.8 million or $0.53 per diluted share compared to a net loss of $2.5 million or $(0.11) per diluted share, in the same period last year.

 

As of September 30, 2024, the Company had cash and cash equivalents of $1.2 million compared to $1.0 million on December 31, 2023.

 

Nine-Months 2024 Financial Results

 

Revenues increased 46% to $27.0 million compared to $18.5 million in the same period last year. The increase was primarily because revenue recognized from warrants and ordinary shares associated with the successful listing of two Go IPO consulting service clients in current periods was greater than that of recognized in the nine months ended September 30, 2023.

 

Gross profit increased 117% to $17.3 million compared to $8.0 million in the same period last year. The increase was primarily due to the aforementioned reason above.

 

Operating expenses decreased to $7.3 million compared to $8.9 million in the same period last year. The decrease was primarily due to lower selling and general and administrative expenses.

 

Net income increased 506% to $7.1 million or $0.37 per diluted share compared to a net loss of $1.8 million or $(0.07) per diluted share, in the same period last year.

 

About HeartCore Enterprises, Inc.

 

Headquartered in Tokyo, Japan, HeartCore Enterprises is a leading enterprise software and consulting services company. HeartCore offers Software as a Service (SaaS) solutions to enterprise customers in Japan and worldwide. The Company also provides data analytics services that allow enterprise businesses to create tailored web experiences for their clients through best-in-class design. HeartCore’s customer experience management platform (CXM Platform) includes marketing, sales, service and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. HeartCore also operates a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises. HeartCore’s GO IPOSM consulting services helps Japanese-based companies go public in the U.S. Additional information about the Company’s products and services is available at and https://heartcore-enterprises.com/.

 

 

 

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

 

HeartCore Investor Relations Contact:

 

Gateway Group, Inc.

Matt Glover and John Yi

HTCR@gateway-grp.com

(949) 574-3860

 

 

 

 

HEARTCORE ENTERPRISES, INC.

CONSOLIDATED BALANCE SHEETS

 

    September 30,     December 31,  
    2024     2023  
    (Unaudited)        
ASSETS            
Current assets:                
Cash and cash equivalents   $ 1,232,117     $ 1,012,479  
Accounts receivable     2,578,855       2,623,682  
Investments in marketable securities     7,349,575       642,348  
Investment in equity securities     -       300,000  
Prepaid expenses     769,183       536,865  
Current portion of long-term note receivable     100,000       100,000  
Due from related party     43,852       44,758  
Other current assets     177,381       234,761  
Total current assets     12,250,963       5,494,893  
                 
Non-current assets:                
Accounts receivable, non-current     766,972       -  
Property and equipment, net     663,447       763,730  
Operating lease right-of-use assets     2,184,344       2,467,889  
Intangible asset, net     4,037,500       4,515,625  
Goodwill     3,276,441       3,276,441  
Long-term investment in SAFE     350,000       -  
Long-term investment in equity securities     300,000       -  
Long-term investment in warrants     551,787       2,004,308  
Long-term note receivable     200,000       200,000  
Deferred tax assets     392,617       369,436  
Security deposits     336,117       348,428  
Long-term loan receivable from related party     146,354       182,946  
Other non-current assets     15,812       71  
Total non-current assets     13,221,391       14,128,874  
                 
Total assets   $ 25,472,354     $ 19,623,767  
                 
LIABILITIES AND SHAREHOLDERS’ EQUITY                
                 
Current liabilities:                
Accounts payable and accrued expenses   $ 1,779,799     $ 1,757,038  
Accounts payable and accrued expenses - related party     28,772       -  
Accrued payroll and other employee costs     633,514       723,305  
Due to related party     1,438       1,476  
Short-term debt     -       135,937  
Current portion of long-term debts     462,121       371,783  
Insurance premium financing     65,392       -  
Factoring liability     305,472       562,767  
Operating lease liabilities, current     382,594       396,535  
Finance lease liabilities, current     17,375       17,445  
Income tax payables     170,453       162,689  
Deferred revenue     1,927,582       2,166,175  
Other current liabilities     756,766       216,405  
Total current liabilities     6,531,278       6,511,555  
      -          
Non-current liabilities:                
Long-term debts     1,382,048       1,770,352  
Operating lease liabilities, non-current     1,859,948       2,135,160  
Finance lease liabilities, non-current     52,005       66,779  
Deferred tax liabilities     1,130,500       1,264,375  
Other non-current liabilities     200,818       208,732  
Total non-current liabilities     4,625,319       5,445,398  
                 
Total liabilities     11,156,597       11,956,953  
                 
Shareholders’ equity:                
Preferred shares ($0.0001 par value, 20,000,000 shares authorized, no shares issued and outstanding as of September 30, 2024 and December 31, 2023)     -       -  
Common shares ($0.0001 par value, 200,000,000 shares authorized; 20,864,144 and 20,842,690 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively)     2,085       2,083  
Additional paid-in capital     18,997,059       19,594,801  
Accumulated deficit     (6,990,113 )     (14,763,469 )
Accumulated other comprehensive income     392,397       331,881  
Total HeartCore Enterprises, Inc. shareholders’ equity     12,401,428       5,165,296  
Non-controlling interests     1,914,329       2,501,518  
Total shareholders’ equity     14,315,757       7,666,814  
                 
Total liabilities and shareholders’ equity   $ 25,472,354     $ 19,623,767  

 

 

 

 

HEARTCORE ENTERPRISES, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

 

    For the nine months ended September 30,     For the three months ended September 30,  
    2024     2023     2024     2023  
                         
Revenues   $ 26,963,531     $ 18,518,431     $ 17,850,411     $ 4,688,908  
Cost of revenues     9,708,074       10,548,245       3,433,024       3,860,241  
Gross profit     17,255,457       7,970,186       14,417,387       828,667  
                                 
Operating expenses:                                
Selling expenses     642,225       1,330,747       243,110       274,043  
General and administrative expenses     6,395,429       7,305,392       1,966,717       2,172,298  
Research and development expenses     307,931       289,303       107,529       170,071  
Total operating expenses     7,345,585       8,925,442       2,317,356       2,616,412  
                                 
Income (loss) from operations     9,909,872       (955,256 )     12,100,031       (1,787,745 )
                                 
Other income (expenses):                                
Changes in fair value of investments in marketable securities     (308,059 )     (500,762 )     122,272       (271,740 )
Changes in fair value of investment in warrants     1,631,700       (294,565 )     2,869,407       (460,672 )
Loss on sale of warrants     (3,970,628 )     -       (3,970,628 )     -  
Interest income     15,557       64,633       10,933       14,363  
Interest expenses     (105,094 )     (125,073 )     (31,393 )     (42,619 )
Other income     158,914       176,641       24,040       52,640  
Other expenses     (131,507 )     (62,701 )     (82,457 )     (25,947 )
Total other expenses     (2,709,117 )     (741,827 )     (1,057,826 )     (733,975 )
                                 
Income (loss) before income tax provision     7,200,755       (1,697,083 )     11,042,205       (2,521,720 )
                                 
Income tax expense     72,945       58,859       225,275       19,413  
                                 
Net income (loss)     7,127,810       (1,755,942 )     10,816,930       (2,541,133 )
Less: net loss attributable to non-controlling interests     (645,546 )     (419,211 )     (240,876 )     (233,913 )
Net income (loss) attributable to HeartCore Enterprises, Inc.   $ 7,773,356     $ (1,336,731 )   $ 11,057,806     $ (2,307,220 )
                                 
Other comprehensive income (loss):                                
Foreign currency translation adjustment     51,678       (85,244 )     65,503       (90,743 )
                                 
Total comprehensive income (loss)     7,179,488       (1,841,186 )     10,882,433       (2,631,876 )
Less: comprehensive loss attributable to non-controlling interests     (654,384 )     (422,352 )     (241,913 )     (235,094 )
Comprehensive income (loss) attributable to HeartCore Enterprises, Inc.   $ 7,833,872     $ (1,418,834 )   $ 11,124,346     $ (2,396,782 )
                                 
Net income (loss) per common share attributable to HeartCore Enterprises, Inc.                                
Basic   $ 0.37     $ (0.07 )   $ 0.53     $ (0.11 )
Diluted   $ 0.37     $ (0.07 )   $ 0.53     $ (0.11 )
                                 
Weighted average common shares outstanding                                
Basic     20,861,012       20,257,020       20,864,144       20,842,690  
Diluted     20,861,012       20,257,020       20,864,144       20,842,690  

 

 

 

 

HEARTCORE ENTERPRISES, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

    For the nine months ended September 30,  
    2024     2023  
             
Cash flows from operating activities                
Net income (loss)   $ 7,127,810     $ (1,755,942 )
Adjustments to reconcile net income (loss) to net cash flows used in operating activities:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation and amortization expenses     561,659       495,200  
Loss (gain) on disposal of property and equipment     1,894       (4,737 )
Amortization of debt issuance costs     3,791       2,257  
Non-cash lease expense     272,208       254,876  
Loss (gain) on termination of lease     (469 )     76  
Deferred income taxes     (163,199 )     (109,690 )
Stock-based compensation     236,826       1,267,699  
Marketable securities received as noncash consideration     (572,010 )     -  
Warrants received as noncash consideration     (12,969,683 )     (4,009,335 )
Changes in fair value of investments in marketable securities     308,059       500,762  
Changes in fair value of investment in warrants     (1,631,700 )     294,565  
Loss on sale of warrants     3,970,628       -  
Changes in assets and liabilities:                
Accounts receivable     (685,531 )     (322,583 )
Prepaid expenses     (72,315 )     187,269  
Other assets     40,761       (23,982 )
Accounts payable and accrued expenses     34,752       597,247  
Accounts payable and accrued expenses - related party     28,315       -  
Accrued payroll and other employee costs     (68,323 )     7,471  
Due to related party     (7 )     7,562  
Operating lease liabilities     (275,850 )     (231,499 )
Income tax payables     17,971       101,058  
Deferred revenue     (205,109 )     200,256  
Other liabilities     540,008       83,809  
Net cash flows used in operating activities     (3,499,514 )     (2,457,661 )
                 
Cash flows from investing activities                
Purchases of property and equipment     (4,134 )     (516,658 )
Proceeds from disposal of property and equipment     -       24,935  
Advance on note receivable     -       (600,000 )
Purchase of long-term investment in SAFE     (350,000 )     -  
Net proceeds from sale of warrants     5,640,000       -  
Repayment of loan provided to related party     31,457       34,823  
Payment for acquisition of subsidiary, net of cash acquired     -       (724,910 )
Net cash flows provided by (used in) investing activities     5,317,323       (1,781,810 )
                 
Cash flows from financing activities                
Payments for finance leases     (12,568 )     (16,537 )
Proceeds from short-term and long-term debts     68,138       219,427  
Repayment of short-term and long-term debts     (453,048 )     (584,779 )
Repayment of insurance premium financing     (107,297 )     (266,756 )
Net proceeds from factoring arrangement     -       217,250  
Net repayment of factoring arrangement     (257,295 )     -  
Payments for debt issuance costs     -       (656 )
Distribution of dividends     (834,566 )     -  
Capital contribution from non-controlling shareholder     67,195       -  
Net cash flows used in financing activities     (1,529,441 )     (432,051 )
                 
Effect of exchange rate changes     (68,730 )     (306,239 )
                 
Net change in cash and cash equivalents     219,638       (4,977,761 )
                 
Cash and cash equivalents - beginning of the period     1,012,479       7,177,326  
                 
Cash and cash equivalents - end of the period   $ 1,232,117     $ 2,199,565  
                 
Supplemental cash flow disclosures:                
Interest paid   $ 104,880     $ 59,290  
Income taxes paid   $ 201,035     $ 91,657  
                 
Non-cash investing and financing transactions                
Operating lease right-of-use assets obtained in exchange for operating lease liabilities   $ 125,735     $ 317,040  
Finance lease right-of-use assets obtained in exchange for finance lease liabilities   $ -     $ 93,117  
Remeasurement of operating lease liabilities and right-of-use assets due to lease modification   $ -     $ 12,579  
Insurance premium financing   $ 172,689     $ 389,035  
Liabilities assumed in connection with purchase of property and equipment   $ -     $ 9,602  
Common shares issued for acquisition of subsidiary   $ -     $ 3,150,000  
Warrants converted to marketable securities   $ 6,443,276     $ 1,257,868